Exponential Volume Spike: CV THERAPEUTICS (CVTX)
CV Therapeutics, Inc. (NASDAQ: CVTX) is seeing a major surge in trading volume this morning. The company’s partner, Astellas, has has sent a $16.00 buyout to the company and traders are betting that an even higher premium could be headed its way. As 0f 8:53 AM EST we have seen a 50% pop to $17.00 [...]
VS Investor RSS Feed